These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 4954934)

  • 1. [Experimental trials and clinical observations on the use of intravenous morphazinamide in chronic pulmonary tuberculosis].
    Di Perna A; Berti R; Cinotti D
    Minerva Med; 1965 Sep; 56(71):2872-8. PubMed ID: 4954934
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of chronic destructive pulmonary tuberculosis by intravenous injections of morphazinamide].
    Utkin VV; Zankisova IG; Polishchuk AK; Krylova NP; Gridneva SM
    Vrach Delo; 1972 Feb; 2():57-8. PubMed ID: 5084744
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical observations on morphazinamide administered by intravenous perfusion in therapy of pulmonary tuberculosis].
    Lucchesi M; Pallotta G; Fantoli U
    Minerva Med; 1965 Sep; 56(71):2914-8. PubMed ID: 5322276
    [No Abstract]   [Full Text] [Related]  

  • 4. [Morphazinamide by venous perfusion in therapy of pulmonary tuberculosis].
    Leoncini G; Bolondi O; Costi TF
    Minerva Med; 1965 Sep; 56(71):2910-3. PubMed ID: 5322275
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of morphazinamide in monomedicamentous therapy per os and intravenously in pulmonary tuberculosis].
    Sorrentino F; Calagna L
    Minerva Med; 1965 Sep; 56(71):2938-42. PubMed ID: 5322280
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences with morphazinamide administered in slow venous perfusion in the treatment of pulmonary tuberculosis].
    Censi G; Orlandini GC
    Minerva Med; 1965 Sep; 56(71):2881-92. PubMed ID: 5322269
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intravenous and topical use of morphazinamide in the pre- and post-operative treatment of pulmonary and pleural tuberculosis].
    Maggio L; Tabocchini W
    Minerva Med; 1965 Sep; 56(70):2797-809. PubMed ID: 5853905
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolism and mode of action of morphazinamide. Experimental and clinical reports].
    Bisetti A
    Lotta Tuberc; 1971; 41(3):389-96. PubMed ID: 5003853
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intravenous morphazinamide. Tolerance of the drug and therapeutic effects].
    Celotti A
    Minerva Med; 1965 Sep; 56(71):2892-7. PubMed ID: 5322270
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical observations on morphazinamide administered intravenously in pulmonary tuberculosis].
    Durigato S
    G Ital Chemioter; 1965; 12(1):82-98. PubMed ID: 5881989
    [No Abstract]   [Full Text] [Related]  

  • 11. [On therapeutic effects of morphazinamide, used alone and in association, in recent and chronic pulmonary tuberculosis].
    Pasargiklian M
    Minerva Med; 1965 Sep; 56(71):2855-62. PubMed ID: 5322267
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical findings on curative action of morphazinamide, administered intravenously, to patients with pulmonary tuberculosis].
    Cacciavillani B
    Minerva Med; 1965 Sep; 56(71):2878-81. PubMed ID: 5322268
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of therapy with morphazinamide administered orally in association with other antitubercular drugs].
    Curiale G; Tocco G
    Minerva Med; 1965 Sep; 56(71):2943-8. PubMed ID: 5322281
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the antituberculous activity of morphazinamide and pyrazinamide on chronic experimental tuberculosis. I. The antimycobacterial efficacy made in vitro and in vivo.
    Trnka L; Kuska J; Havel A
    Chemotherapia (Basel); 1964-1965; 9(3):158-67. PubMed ID: 4953657
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of morphazinamide in therapy of tuberculosis in association with other antitubercular drugs and with intravenous, intrapleural and intraperitoneal administration].
    Mariani B
    Minerva Med; 1965 Sep; 56(71):2918-20. PubMed ID: 5322277
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vitro activities of antitubercular agents and intensification of combined chemotherapy of tuberculosis].
    Ooizumi K
    Kekkaku; 1983 Sep; 58(9):490-2. PubMed ID: 6420602
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the antituberculous activity of morphazinamide and pyrazinamide on chronic experimental tuberculosis. II. The emergence of resistance and its retardation in the course of monotherapy and combinations of antituberculous drugs.
    Havel A; Trnka L; Kuska J
    Chemotherapia (Basel); 1964-1965; 9(3):168-75. PubMed ID: 4953658
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the role of formaldehyde in the antimycobacterial action of morphazinamide in vitro].
    Castelli D; Vercellino E; Vercellino A
    G Ital Mal Torace; 1966; 20(5):261-4. PubMed ID: 4967673
    [No Abstract]   [Full Text] [Related]  

  • 19. Higher activity of morphazinamide over pyrazinamide against intracellular.
    Teyssier L
    Int J Tuberc Lung Dis; 2001 Apr; 5(4):386. PubMed ID: 11334260
    [No Abstract]   [Full Text] [Related]  

  • 20. Susceptibility of tubercle myobacteria to antibacterial drugs and its importance for the clinical course of tuberculosis.
    Radanov R; Dobrev P; Kalfin E
    Nauchni Tr Vissh Med Inst Sofiia; 1965; 44(5):27-35. PubMed ID: 4223179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.